Ashwin Ravichandran, MD
Advanced Heart Failure and Transplant Cardiology · Indianapolis, INNPI 1407012776
Payments from drug & device makers
Across 790 payments — averaging $3526.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.1M
- United Therapeutics Corporation$375K
- Abbott$272K
- Endotronix, Inc.$254K
- Actelion Pharmaceuticals, Ltd$128K
- Actelion Pharmaceuticals US, Inc.$128K
- plus $575K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 20 | $1,053,762 |
| United Therapeutics Corporation | 162 | $374,960 |
| Abbott | 239 | $272,420 |
| Endotronix, Inc. | 7 | $254,234 |
| Actelion Pharmaceuticals, Ltd | 20 | $128,109 |
| Actelion Pharmaceuticals US, Inc. | 106 | $127,582 |
| Medtronic(2 entities) | 60 | $124,240 |
| Janssen Research & Development, LLC | 46 | $119,080 |
| American Regent | 22 | $108,780 |
| Insmed, Inc. | 30 | $87,833 |
| E.r. Squibb & Sons, L.L.C. | 6 | $57,824 |
| Briohealth Solutions, Inc. | 2 | $26,285 |
| Bayer | 15 | $22,156 |
| Cvrx, Inc. | 37 | $15,228 |
| Janssen Scientific Affairs, LLC | 3 | $11,900 |
| Abiomed | 4 | $352 |
| Impulse Dynamics (USA) Inc. | 1 | $183 |
| Novartis | 1 | $130 |
| Boston Scientific | 1 | $126 |
| Livanova USA, Inc. | 1 | $125 |
| Angiodynamics, Inc. | 2 | $123 |
| EKOS Corporation | 1 | $111 |
| La Jolla Pharmaceutical Company | 1 | $105 |
| Edwards Lifesciences | 1 | $90 |
| Sandoz | 2 | $64 |
How this compares
$2,785,801 in reported general payments places this provider in the 95th percentile of 20 advanced heart failure and transplant cardiology providers in Indiana.
See all advanced heart failure and transplant cardiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Indianapolis
- Sasikanth AdigopulaIndianapolis$1.2M
- Sunit-Preet ChaudhryIndianapolis$438K
- Mary WalshIndianapolis$278K
- Amit PatelIndianapolis$239K
- Rafael Garcia-CortesIndianapolis$101K
- Bhavana Siddegowda-BangaloreIndianapolis$41K
- Muhamad SafiiaIndianapolis$41K
- Radha KannegantiIndianapolis$18K
- Sangita SudharshanIndianapolis$2K
- Philip KirlinIndianapolis$967
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.